BODY
RNA Editing Moves West: Rznomics Plants Its Flag in Lilly's San Diego Hub
SUMMARY South Korean RNA-editing firm Rznomics has secured a foothold inside Eli Lilly's San Diego innovation hub — a strategic move that signals growing pharma appetite for RNA-based precision gene therapy. Here's what the company is building, and why the address matters.
This is a Pro article
Subscribe to read the full article and support independent AI journalism.